Cargando…
A 10-point plan for avoiding hyaluronic acid dermal filler-related complications during facial aesthetic procedures and algorithms for management
The recent rapid growth in dermal filler use, in conjunction with inadequate product and injector control, has heralded a concerning increase in filler complications. The 10-point plan has been developed to minimize complications through careful preconsideration of causative factors, categorized as...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257077/ https://www.ncbi.nlm.nih.gov/pubmed/30538521 http://dx.doi.org/10.2147/CCID.S180904 |
_version_ | 1783374260238024704 |
---|---|
author | Heydenrych, Izolda Kapoor, Krishan M De Boulle, Koenraad Goodman, Greg Swift, Arthur Kumar, Narendra Rahman, Eqram |
author_facet | Heydenrych, Izolda Kapoor, Krishan M De Boulle, Koenraad Goodman, Greg Swift, Arthur Kumar, Narendra Rahman, Eqram |
author_sort | Heydenrych, Izolda |
collection | PubMed |
description | The recent rapid growth in dermal filler use, in conjunction with inadequate product and injector control, has heralded a concerning increase in filler complications. The 10-point plan has been developed to minimize complications through careful preconsideration of causative factors, categorized as patient, product, and procedure related. Patient-related factors include history, which involves a preprocedural consultation with careful elucidation of skin conditions, systemic disease, medications, and previous cosmetic procedures. Other exclusion criteria include autoimmune diseases and multiple allergies. The temporal proximity of dental or routine medical procedures is discouraged. Insightful patient assessment, with the consideration of ethnicity, gender, and generational needs, is of paramount importance. Specified informed consent is vital due to the concerning increase in vascular complications, which carry the risk for skin compromise and loss of vision. Informed consent should be signed for both adverse events and their treatment. Product-related factors include reversibility, which is a powerful advantage when using hyaluronic acid (HA) products. Complications from nonreversible or minimally degradable products, especially when layered over vital structures, are more difficult to control. Product characteristics such as HA concentration and proprietary cross-linking should be understood in the context of ideal depth, placement, and expected duration. Product layering over late or minimally degradable fillers is discouraged, while layering of HA of over the same brand, or even across brands, seems to be feasible. Procedural factors such as photographic documentation, procedural planning, aseptic technique, and anatomical and technical knowledge are of pivotal importance. A final section is dedicated to algorithms and protocols for the management and treatment of complications such as hypersensitivity, vascular events, infection, and late-onset nodules. The 10-point plan is a systematic, effective strategy aimed at reducing the risk of dermal filler complications. |
format | Online Article Text |
id | pubmed-6257077 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-62570772018-12-11 A 10-point plan for avoiding hyaluronic acid dermal filler-related complications during facial aesthetic procedures and algorithms for management Heydenrych, Izolda Kapoor, Krishan M De Boulle, Koenraad Goodman, Greg Swift, Arthur Kumar, Narendra Rahman, Eqram Clin Cosmet Investig Dermatol Perspectives The recent rapid growth in dermal filler use, in conjunction with inadequate product and injector control, has heralded a concerning increase in filler complications. The 10-point plan has been developed to minimize complications through careful preconsideration of causative factors, categorized as patient, product, and procedure related. Patient-related factors include history, which involves a preprocedural consultation with careful elucidation of skin conditions, systemic disease, medications, and previous cosmetic procedures. Other exclusion criteria include autoimmune diseases and multiple allergies. The temporal proximity of dental or routine medical procedures is discouraged. Insightful patient assessment, with the consideration of ethnicity, gender, and generational needs, is of paramount importance. Specified informed consent is vital due to the concerning increase in vascular complications, which carry the risk for skin compromise and loss of vision. Informed consent should be signed for both adverse events and their treatment. Product-related factors include reversibility, which is a powerful advantage when using hyaluronic acid (HA) products. Complications from nonreversible or minimally degradable products, especially when layered over vital structures, are more difficult to control. Product characteristics such as HA concentration and proprietary cross-linking should be understood in the context of ideal depth, placement, and expected duration. Product layering over late or minimally degradable fillers is discouraged, while layering of HA of over the same brand, or even across brands, seems to be feasible. Procedural factors such as photographic documentation, procedural planning, aseptic technique, and anatomical and technical knowledge are of pivotal importance. A final section is dedicated to algorithms and protocols for the management and treatment of complications such as hypersensitivity, vascular events, infection, and late-onset nodules. The 10-point plan is a systematic, effective strategy aimed at reducing the risk of dermal filler complications. Dove Medical Press 2018-11-23 /pmc/articles/PMC6257077/ /pubmed/30538521 http://dx.doi.org/10.2147/CCID.S180904 Text en © 2018 Heydenrych et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Perspectives Heydenrych, Izolda Kapoor, Krishan M De Boulle, Koenraad Goodman, Greg Swift, Arthur Kumar, Narendra Rahman, Eqram A 10-point plan for avoiding hyaluronic acid dermal filler-related complications during facial aesthetic procedures and algorithms for management |
title | A 10-point plan for avoiding hyaluronic acid dermal filler-related complications during facial aesthetic procedures and algorithms for management |
title_full | A 10-point plan for avoiding hyaluronic acid dermal filler-related complications during facial aesthetic procedures and algorithms for management |
title_fullStr | A 10-point plan for avoiding hyaluronic acid dermal filler-related complications during facial aesthetic procedures and algorithms for management |
title_full_unstemmed | A 10-point plan for avoiding hyaluronic acid dermal filler-related complications during facial aesthetic procedures and algorithms for management |
title_short | A 10-point plan for avoiding hyaluronic acid dermal filler-related complications during facial aesthetic procedures and algorithms for management |
title_sort | 10-point plan for avoiding hyaluronic acid dermal filler-related complications during facial aesthetic procedures and algorithms for management |
topic | Perspectives |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257077/ https://www.ncbi.nlm.nih.gov/pubmed/30538521 http://dx.doi.org/10.2147/CCID.S180904 |
work_keys_str_mv | AT heydenrychizolda a10pointplanforavoidinghyaluronicaciddermalfillerrelatedcomplicationsduringfacialaestheticproceduresandalgorithmsformanagement AT kapoorkrishanm a10pointplanforavoidinghyaluronicaciddermalfillerrelatedcomplicationsduringfacialaestheticproceduresandalgorithmsformanagement AT deboullekoenraad a10pointplanforavoidinghyaluronicaciddermalfillerrelatedcomplicationsduringfacialaestheticproceduresandalgorithmsformanagement AT goodmangreg a10pointplanforavoidinghyaluronicaciddermalfillerrelatedcomplicationsduringfacialaestheticproceduresandalgorithmsformanagement AT swiftarthur a10pointplanforavoidinghyaluronicaciddermalfillerrelatedcomplicationsduringfacialaestheticproceduresandalgorithmsformanagement AT kumarnarendra a10pointplanforavoidinghyaluronicaciddermalfillerrelatedcomplicationsduringfacialaestheticproceduresandalgorithmsformanagement AT rahmaneqram a10pointplanforavoidinghyaluronicaciddermalfillerrelatedcomplicationsduringfacialaestheticproceduresandalgorithmsformanagement AT heydenrychizolda 10pointplanforavoidinghyaluronicaciddermalfillerrelatedcomplicationsduringfacialaestheticproceduresandalgorithmsformanagement AT kapoorkrishanm 10pointplanforavoidinghyaluronicaciddermalfillerrelatedcomplicationsduringfacialaestheticproceduresandalgorithmsformanagement AT deboullekoenraad 10pointplanforavoidinghyaluronicaciddermalfillerrelatedcomplicationsduringfacialaestheticproceduresandalgorithmsformanagement AT goodmangreg 10pointplanforavoidinghyaluronicaciddermalfillerrelatedcomplicationsduringfacialaestheticproceduresandalgorithmsformanagement AT swiftarthur 10pointplanforavoidinghyaluronicaciddermalfillerrelatedcomplicationsduringfacialaestheticproceduresandalgorithmsformanagement AT kumarnarendra 10pointplanforavoidinghyaluronicaciddermalfillerrelatedcomplicationsduringfacialaestheticproceduresandalgorithmsformanagement AT rahmaneqram 10pointplanforavoidinghyaluronicaciddermalfillerrelatedcomplicationsduringfacialaestheticproceduresandalgorithmsformanagement |